{
    "xml": "<topic id=\"PHP34491\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/sofosbuvir\" basename=\"sofosbuvir\" title=\"SOFOSBUVIR\">\n<title>SOFOSBUVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1285\" namespace=\"/interactions/list-of-drug-interactions/antivirals/sofosbuvir\">Sofosbuvir</xref>\n</p>\n<data name=\"vtmid\">24573011000001106</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_708418908\" title=\"Nucleotide analogues\">Nucleotide analogues</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP66100\" outputclass=\"indicationsAndDose\" rev=\"1.38\" parent=\"/drugs/sofosbuvir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">In combination with ribavirin (Copegus<tm tmtype=\"reg\"/>), with or without peginterferon alfa, for chronic hepatitis C infection of genotypes 1, 3, 4, 5, or 6 in patients with compensated liver disease</p>\n<p outputclass=\"therapeuticIndication\">In combination with ribavirin (Copegus<tm tmtype=\"reg\"/>) for chronic hepatitis C infection of genotype 2 in patients with compensated liver disease</p>\n<p outputclass=\"therapeuticIndication\">In combination with daclatasvir for chronic hepatitis C infection of genotype 1, 3, or 4</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg once daily, for duration of treatment consult product literature.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66170\" outputclass=\"cautions\" rev=\"1.11\" parent=\"/drugs/sofosbuvir\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p>In chronic hepatitis C of genotype 1, 4, 5, or 6, only use sofosbuvir with ribavirin in those with intolerance or contra-indications to peginterferon alfa who require urgent treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66090\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/sofosbuvir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (sofosbuvir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65964\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/sofosbuvir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal discomfort (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">agitation (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">alopecia (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">anaemia (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">anxiety (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">arthralgia (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">asthenia (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">blurred vision (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">chest pain (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">constipation (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">cough (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">decreased appetite (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">depression (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">diarrhoea (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">disturbance in attention (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">dizziness (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">dry mouth (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">dyspnoea (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">gastro-oesophageal reflux (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">headache (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">insomnia (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">irritability (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">memory impairment (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">migraine (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">myalgia (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">nausea (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">neutropenia (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">rash (in combination with ribavirin)</ph>; <ph outputclass=\"sideEffect\">vomiting (in combination with ribavirin and peginterferon alfa)</ph>; <ph outputclass=\"sideEffect\">weight loss (in combination with ribavirin and peginterferon alfa)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66074\" outputclass=\"pregnancy\" parent=\"/drugs/sofosbuvir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66181\" outputclass=\"breastFeeding\" parent=\"/drugs/sofosbuvir\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;metabolites present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66025\" outputclass=\"renalImpairment\" parent=\"/drugs/sofosbuvir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Safety and efficacy not established if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>&#8212;accumulation may occur.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58244\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/sofosbuvir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dispense in original container (contains desiccant).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66050\" outputclass=\"patientAndCarerAdvice\" rev=\"1.8\" parent=\"/drugs/sofosbuvir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundMissedDoses\">\n<title>Missed doses</title>\n<sectiondiv>\n<p>If a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65882\" outputclass=\"nationalFunding\" rev=\"1.18\" parent=\"/drugs/sofosbuvir\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA330</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Sofosbuvir for treating chronic hepatitis C (February 2015)</p>\r\n<p>Sofosbuvir in combination with peginterferon alfa and ribavirin is an option for treating adults with chronic hepatitis C infection:</p>\r\n<ul>\r\n<li>of genotype 1</li>\r\n<li>of genotype 3 with cirrhosis (treatment naive patients)</li>\r\n<li>of genotype 3 that has not adequately responded to interferon-based treatment</li>\r\n<li>of genotype 4, 5, or 6 with cirrhosis</li>\r\n</ul>\r\n<p>Sofosbuvir in combination with ribavirin is an option for treating adults with chronic hepatitis C infection:</p>\r\n<ul>\r\n<li>of genotype 2 who are intolerant to <i>or</i> ineligible for interferon (treatment naive patients)</li>\r\n<li>of genotype 2 that has not adequately responded to interferon-based treatment</li>\r\n<li>of genotype 3 with cirrhosis who are intolerant to <i>or</i> ineligible for interferon (treatment naive patients)</li>\r\n<li>of genotype 3 with cirrhosis that has not adequately responded to interferon-based treatment</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA330\">www.nice.org.uk/TA330</xref>\n</sectiondiv>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA330</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Sofosbuvir for treating chronic hepatitis C (February 2015)</p>\r\n<p>Sofosbuvir in combination with ribavirin is not recommended for the treatment of adults with chronic hepatitis C infection of genotypes 1, 4, 5, or 6.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA330\">www.nice.org.uk/TA330</xref>\n</sectiondiv>\n</sectiondiv>\r\n<sectiondiv outputclass=\"smcDecisions\">\r\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\r\n<sectiondiv outputclass=\"smcDecision\">\r\n<sectiondiv>\r\n<p>The <i>Scottish Medicines Consortium</i> has advised (June 2014) that sofosbuvir (<i>Sovaldi</i>\r\n<tm tmtype=\"reg\"/>) is accepted for use within NHS Scotland for the treatment of chronic hepatitis C infection of genotypes 1 to 6; its use in combination with ribavirin as dual therapy for chronic hepatitis C infection of either genotype 2 (in treatment naive patients) or genotype 3 is restricted to those who cannot use peginterferon alfa because of intolerance or contra-indications.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP34491-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/sofosbuvir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101313\" title=\"Tablet\" namespace=\"/drugs/sofosbuvir/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107699\" namespace=\"/about/changes\" title=\"Changes\" count=\"1\" rel=\"backlink\">Changes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78120\" namespace=\"/treatment-summaries/respiratory-syncytial-virus\" title=\"Respiratory syncytial virus\" count=\"2\" rel=\"backlink\">Respiratory syncytial virus</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78240\" namespace=\"/treatment-summaries/hepatitis\" title=\"Hepatitis\" count=\"5\" rel=\"backlink\">Hepatitis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1285\" namespace=\"/interactions/list-of-drug-interactions/antivirals/sofosbuvir\" title=\"Sofosbuvir\" count=\"1\" rel=\"link\">Sofosbuvir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101313\" namespace=\"/drugs/sofosbuvir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP34491",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/sofosbuvir",
    "basename": "sofosbuvir",
    "title": "SOFOSBUVIR",
    "interactants": [
        {
            "id": "bnf_int_1285",
            "label": "Sofosbuvir"
        }
    ],
    "vtmid": "24573011000001106",
    "drugClassification": [
        "Nucleotide analogues"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "In combination with ribavirin (Copegus), with or without peginterferon alfa, for chronic hepatitis C infection of genotypes 1, 3, 4, 5, or 6 in patients with compensated liver disease",
                        "html": "In combination with ribavirin (Copegus<tm tmtype=\"reg\"/>), with or without peginterferon alfa, for chronic hepatitis C infection of genotypes 1, 3, 4, 5, or 6 in patients with compensated liver disease"
                    },
                    {
                        "textContent": "In combination with ribavirin (Copegus) for chronic hepatitis C infection of genotype 2 in patients with compensated liver disease",
                        "html": "In combination with ribavirin (Copegus<tm tmtype=\"reg\"/>) for chronic hepatitis C infection of genotype 2 in patients with compensated liver disease"
                    },
                    {
                        "textContent": "In combination with daclatasvir for chronic hepatitis C infection of genotype 1, 3, or 4",
                        "html": "In combination with daclatasvir for chronic hepatitis C infection of genotype 1, 3, or 4"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "400 mg once daily, for duration of treatment consult product literature.",
                        "html": "<p>400&#8239;mg once daily, for duration of treatment consult product literature.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "In chronic hepatitis C of genotype 1, 4, 5, or 6, only use sofosbuvir with ribavirin in those with intolerance or contra-indications to peginterferon alfa who require urgent treatment.",
                "html": "<p>In chronic hepatitis C of genotype 1, 4, 5, or 6, only use sofosbuvir with ribavirin in those with intolerance or contra-indications to peginterferon alfa who require urgent treatment.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (sofosbuvir).",
                "html": "<p>Appendix 1 (sofosbuvir).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal discomfort (in combination with ribavirin)",
                        "html": "Abdominal discomfort (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "agitation (in combination with ribavirin and peginterferon alfa)",
                        "html": "agitation (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "alopecia (in combination with ribavirin)",
                        "html": "alopecia (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anaemia (in combination with ribavirin)",
                        "html": "anaemia (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anxiety (in combination with ribavirin and peginterferon alfa)",
                        "html": "anxiety (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "arthralgia (in combination with ribavirin)",
                        "html": "arthralgia (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "asthenia (in combination with ribavirin)",
                        "html": "asthenia (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blurred vision (in combination with ribavirin and peginterferon alfa)",
                        "html": "blurred vision (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "chest pain (in combination with ribavirin and peginterferon alfa)",
                        "html": "chest pain (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "constipation (in combination with ribavirin)",
                        "html": "constipation (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cough (in combination with ribavirin)",
                        "html": "cough (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "decreased appetite (in combination with ribavirin and peginterferon alfa)",
                        "html": "decreased appetite (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression (in combination with ribavirin)",
                        "html": "depression (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea (in combination with ribavirin and peginterferon alfa)",
                        "html": "diarrhoea (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "disturbance in attention (in combination with ribavirin)",
                        "html": "disturbance in attention (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness (in combination with ribavirin and peginterferon alfa)",
                        "html": "dizziness (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dry mouth (in combination with ribavirin and peginterferon alfa)",
                        "html": "dry mouth (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspnoea (in combination with ribavirin)",
                        "html": "dyspnoea (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-oesophageal reflux (in combination with ribavirin)",
                        "html": "gastro-oesophageal reflux (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache (in combination with ribavirin)",
                        "html": "headache (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "influenza-like symptoms (in combination with ribavirin)",
                        "html": "influenza-like symptoms (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insomnia (in combination with ribavirin)",
                        "html": "insomnia (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "irritability (in combination with ribavirin)",
                        "html": "irritability (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "memory impairment (in combination with ribavirin and peginterferon alfa)",
                        "html": "memory impairment (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "migraine (in combination with ribavirin and peginterferon alfa)",
                        "html": "migraine (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia (in combination with ribavirin)",
                        "html": "myalgia (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea (in combination with ribavirin)",
                        "html": "nausea (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "neutropenia (in combination with ribavirin and peginterferon alfa)",
                        "html": "neutropenia (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash (in combination with ribavirin)",
                        "html": "rash (in combination with ribavirin)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting (in combination with ribavirin and peginterferon alfa)",
                        "html": "vomiting (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight loss (in combination with ribavirin and peginterferon alfa)",
                        "html": "weight loss (in combination with ribavirin and peginterferon alfa)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid.",
                "html": "<p>Manufacturer advises avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;metabolites present in milk in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;metabolites present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Safety and efficacy not established if eGFR less than 30 mL/minute/1.73 m2&#8212;accumulation may occur.",
                "html": "<p>Safety and efficacy not established if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>&#8212;accumulation may occur.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dispense in original container (contains desiccant).",
                "html": "<p>Dispense in original container (contains desiccant).</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundMissedDoses": [
            {
                "type": "adviceAroundMissedDoses",
                "textContent": "If a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.",
                "html": "<p>If a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA330",
                        "label": "www.nice.org.uk/TA330"
                    }
                ],
                "fundingIdentifier": "NICE TA330",
                "textContent": "Sofosbuvir for treating chronic hepatitis C (February 2015) Sofosbuvir in combination with peginterferon alfa and ribavirin is an option for treating adults with chronic hepatitis C infection: of genotype 1 of genotype 3 with cirrhosis (treatment naive patients) of genotype 3 that has not adequately responded to interferon-based treatment of genotype 4, 5, or 6 with cirrhosis Sofosbuvir in combination with ribavirin is an option for treating adults with chronic hepatitis C infection: of genotype 2 who are intolerant to or ineligible for interferon (treatment naive patients) of genotype 2 that has not adequately responded to interferon-based treatment of genotype 3 with cirrhosis who are intolerant to or ineligible for interferon (treatment naive patients) of genotype 3 with cirrhosis that has not adequately responded to interferon-based treatment\n\nwww.nice.org.uk/TA330",
                "html": "<p outputclass=\"title\">Sofosbuvir for treating chronic hepatitis C (February 2015)</p> <p>Sofosbuvir in combination with peginterferon alfa and ribavirin is an option for treating adults with chronic hepatitis C infection:</p> <ul> <li>of genotype 1</li> <li>of genotype 3 with cirrhosis (treatment naive patients)</li> <li>of genotype 3 that has not adequately responded to interferon-based treatment</li> <li>of genotype 4, 5, or 6 with cirrhosis</li> </ul> <p>Sofosbuvir in combination with ribavirin is an option for treating adults with chronic hepatitis C infection:</p> <ul> <li>of genotype 2 who are intolerant to <i>or</i> ineligible for interferon (treatment naive patients)</li> <li>of genotype 2 that has not adequately responded to interferon-based treatment</li> <li>of genotype 3 with cirrhosis who are intolerant to <i>or</i> ineligible for interferon (treatment naive patients)</li> <li>of genotype 3 with cirrhosis that has not adequately responded to interferon-based treatment</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA330\">www.nice.org.uk/TA330</xref>"
            },
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA330",
                        "label": "www.nice.org.uk/TA330"
                    }
                ],
                "fundingIdentifier": "NICE TA330",
                "textContent": "Sofosbuvir for treating chronic hepatitis C (February 2015) Sofosbuvir in combination with ribavirin is not recommended for the treatment of adults with chronic hepatitis C infection of genotypes 1, 4, 5, or 6.\n\nwww.nice.org.uk/TA330",
                "html": "<p outputclass=\"title\">Sofosbuvir for treating chronic hepatitis C (February 2015)</p> <p>Sofosbuvir in combination with ribavirin is not recommended for the treatment of adults with chronic hepatitis C infection of genotypes 1, 4, 5, or 6.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA330\">www.nice.org.uk/TA330</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP101313",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "treatmentSummary": [
            {
                "id": "PHP107699",
                "label": "Changes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78120",
                "label": "Respiratory syncytial virus",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78240",
                "label": "Hepatitis",
                "type": "treatmentSummary"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1285",
                "label": "Sofosbuvir",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP101313",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}